The Shafallah Center
05 Junio 2006 - 10:16AM
UK Regulatory
RNS Number:0686E
Amphion Innovations PLC
05 June 2006
Amphion Innovations Partner Company Motif BioSciences Advised in the Design and
Development of The Shafallah Center's Genetics Medical Center in Doha, Qatar
NEW YORK, June 5, 2006 - Amphion Innovations plc (LSE:AMP - News; "Amphion"), a
leading developer and operator of companies in the life sciences and medical
technology sectors, today announced that its partner company, Motif BioSciences,
Inc., played an instrumental role in the design and development of The Shafallah
Center's Genetics Medical Center (SGMC) at the Shafallah Center for Children
with Special Needs, which opened last month in Doha, Qatar.
Motif, working with personnel from the Shafallah Center, assisted in the
procurement of the design, identified the leading instrument vendors and
assisted in installation of the SGMC, a first-of-its-kind genetics laboratory
dedicated to conducting research on disorders that afflict the children of
Qatar. These include rare autosomal recessive diseases, many of which are
unique or first-discovered in the Gulf, as well as more common complex diseases
such as autism and diabetes. The SGMC will anchor The Shafallah Center's
advance to becoming a world-class center of research excellence along with its
existing focus on clinical treatment, special education and related medical
services.
Motif selected the Illumina(R) genotyping BeadLab to anchor the SGMC
installation. Illumina's technology platform enables large-scale disease
association studies and a complete, end-to-end genetic analysis solution with
extensive automation, positive sample tracking, and industry-leading whole-
genome scanning performance.
According to Richard Morgan, CEO of Amphion and Chairman of Motif, "The opening
of The Shafallah Genetics Medical Center is surely one of the most important
developments in this region when it comes to performing world class medical
research. We are both honored and delighted to be part of this ambitious
initiative."
About The Shafallah Center
The Shafallah Center for Children with Special Needs (www.shafallah.org.qa) was
established at the behest of Her Highness Sheikha Mozah bint Nasser al Misnad,
Consort of His Highness the Emir of the State of Qatar, with the intent of
providing comprehensive services for need-based Qatari children. The Center is
a non-profit, private institution and it is chaired by Hassan Ali Bin Ali.
About Motif Biosciences, Inc.
Motif BioSciences, Inc. (http://www.motifbio.com) is a population genetics
company focused on discovering genetic causes of major diseases by interpreting
the wealth of genomic data from Arabian Gulf Region.
For More Information:
Motif BioSciences, Inc
Richard Morgan
1 (212) 210-6224
Aaron Kwittken, Investor Relations
1 (646) 747-7144
Financial Dynamics
Ben Atwell / John Gilbert
+44 (0) 20 7831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEASKSEENKEFE
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024
Real-Time news about Amphion Innovations Plc (London Stock Exchange): 0 recent articles
Más de Amphion Innovations Artículos de Noticias